Involvement of interleukin-6 and androgen receptor signaling in pancreatic cancer

Genes and Cancer

Volumn 1, Issue 8, 2010, Pages 859-867

  Okitsu, Kohichiroh ^a   Kanda, Tatsuo ^a   Imazeki, Fumio ^a   Yonemitsu, Yutaka ^a   Ray, Ratna B ^b   Chang, Chawnshang ^c   Yokosuka, Osamu ^a  

^a CHIBA UNIVERSITY   (Japan)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Androgen receptor; IL 6; Pancreatic cancer; STAT3

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ANDROGEN RECEPTOR; INTERLEUKIN 6; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; SMALL INTERFERING RNA; STAT PROTEIN; STAT3 PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MALE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; RISK FACTOR; SIGNAL TRANSDUCTION;

EID: 79952830388     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601910383417     Document Type: Article

References (43)

1. Raimondi S, Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol. 2009;6: 699-708.
2. Freitas D, Fernandes Gdos S, Hoff PM, Cunha JE. Medical management of pancreatic adenocarcinoma. Pancreatology. 2009;9:223-32.
3. Center for Cancer Control and Information Services, National Cancer Center, Japan. Cancer Statistics in Japan. Cited 2010 Apr 1. Available from: http://www.ncc.go.jp/index.html
4. Rozen P, Liphshitz I, Rosner G, et al. Israeli Pancreatic Cancer Consortium. Pancreatic Cancer in Israel: the epidemiology, possibilities of prevention, early detection and screening. Isr Med Assoc J. 2009;11:710-3.
5. Stewart SL, Cardinez CJ, Richardson LC, et al. Centers for Disease Control and Prevention (CDC). Surveillance for cancers associated with tobacco use: United States, 1999-2004. MMWR Surveill Summ. 2008;57:1-33.
6. Corbishley TP, Iqbal M, Wilkinson ML, Williams R. Androgen receptor in human normal and malignant pancreatic tissue and cell lines. Cancer. 1986;57:1992-5.
7. Greenway BA. Androgen receptor-blocking agents: potential role in pancreatic cancer. Drug Aging. 2000;17:161-3.
8. Gelmann EP. Molecular biology of the androgen receptor. J Clin Oncol. 2002;20:3001-15.
9. Heinlein CA, Chang C. Androgen receptor in prostate cancer. Endocrinol Rev. 2004;25:276-308.
10. Chen CD, Welsbie DS, Tran C, et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med. 2004;10:33-9.
11. Bolton EC, So AY, Chaivorapol C, Haqq CM, Li H, Yamamoto KR. Cell-and gene-specific regulation of primary target genes by the androgen receptor. Genes Dev. 2007;21:2005-17.
12. Yoon G, Kim JY, Choi YK, Won YS, Lim IK. Direct activation of TGF-beta1 transcription by androgen and androgen receptor complex in Huh7 human hepatoma cells and its tumor in nude mice. J Cell Biochem. 2006;97:393-411.
13. Noh KW, Pungpapong S, Wallace MB, Woodward TA, Raimondo W. Do cytokine concentrations in pancreatic juice predict the presence of pancreatic diseases? Clin Gastroenterol Hepatol. 2006;4:782-9.
14. Feurino LW, Zhang Y, Bharadwaj U, et al. IL-6 stimulates Th2 type cytokine secretion and upregulates VEGF and NRP-1 expression in pancreatic cancer cells. Cancer Biol Ther. 2007;6:1096-100.
15. Kishimoto T. Interleukin-6. From basic science to medicine: 40 years in immunology. Annu Rev Immunol. 2005;23:1-21.
16. Germain D, Frank DA. Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy. Clin Cancer Res. 2007;13:5665-9.
17. Coppola D. Molecular prognostic markers in pancreatic cancer. Cancer Control. 2000;7:421-7.
18. Yu H, Kortylewski M, Pardoll D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol. 2007;7:41-51.
19. Carballo M, Conde M, El Bekay R, et al. Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J Biol Chem. 1999;274:17580-6.
20. Madamanchi NR, Li S, Patterson C, Runge MS. Reactive oxygen species regulate heat-shock protein 70 via the JAK/STAT pathway. Arterioscler Thromb Vasc Biol. 2001;21:321-6.
21. Schaefer LK, Wang S, Schaefer TS. c-Src activates the DNA binding and transcriptional activity of Stat3 molecules: serine 727 is not required for transcriptional activation under certain circumstances. Biochem Biophys Res Commun. 1999;266:481-7.
22. Shen Y, Schlessinger K, Zhu X, et al. Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation. Mol Cell Biol. 2004;24:407-19.
23. Decker T, Kovarik P. Serine phosphorylation of STATs. Oncogene. 2000;19:2628-37.
24. Ueda T, Bruchovsky N, Sadar MD. Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. J Biol Chem. 2002;277:7076-85.
25. Furukawa T. Molecular targeting therapy for pancreatic cancer: current knowledge and perspectives from bench to bedside. J Gastroenterol. 2008;43:905-11.
26. Yang L, Wang L, Lin HK, et al. Interleukin-6 differentially regulates androgen receptor transactivation via PI3K-Akt, STAT3, and MAPK, three distinct signal pathways in prostate cancer cells. Biochem Biophys Res Commun. 2003;305:462-9.
27. Kanda T, Steele R, Ray R, Ray RB. Hepatitis C virus core protein augments androgen receptor-mediated signaling. J Virol. 2008;82:11066-72.
28. Bromberg JF, Wrzeszczynska MH, Devgan G, et al. Stat3 as an oncogene. Cell. 1999;98:295-303.
29. Chuang KH, Altuwaijri S, Li G, et al. Neutropenia with impaired host defense against microbial infection in mice lacking androgen receptor. J Exp Med. 2009;206:1181-99.
30. Panopoulos AD, Zhang L, Snow JW, et al. STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. Blood. 2006;108:3682-90.
31. Grivennikov S, Karin M. Autocrine IL-6 signaling: a key event in tumorigenesis? Cancer Cell. 2008;13:7-9.
32. Rebouissou S, Amessou M, Couchy G, et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature. 2009;457:200-5.
33. Konduri S, Schwarz MA, Cafasso D, Schwarz RE. Androgen receptor blockade in experimental combination therapy of pancreatic cancer. J Surg Res. 2007;142:378-86.
34. Grivennikov S, Karin E, Terzic J, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitisassociated cancer. Cancer Cell. 2009;15:103-13.
35. Zhang D, Sun M, Samols D, Kushner I. STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J Biol Chem. 1996;271:9503-9.
36. Tingstedt B, Johansson P, Andersson B, Anderson R. Predictive factors in pancreatic ductal adenocarcinoma: role of the inflammatory response. Scand J Gastroenterol. 2007;42:754-9.
37. Kanda T, Tada M, Imazeki F, Yokosuka O, Nagao K, Saisho H. 5-aza-2'-deoxycytidine sensitizes hepatoma and pancreatic cancer cell lines. Oncol Rep. 2005;14:975-9.
38. Litvinov IV, Chang C, Isaacs JT. Molecular characterization of the commonly used human androgen receptor expression vector, pSG5- AR. Prostate. 2004;58:319-24.
39. Ma WL, Hsu CL, Wu MH, et al. Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology. 2008;135:947-55.
40. Yoshida T, Hanada T, Tokuhisa T, et al. Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J Exp Med. 2003;196:641-53.
41. Nakamoto S, Kanda T, Yonemitsu Y, et al. Quantification of hepatitis C amino acid substitutions 70 and 91 in the core coding region by realtime amplification refractory mutation system reverse transcriptionpolymerase chain reaction. Scand J Gastroenterol. 2009;44:872-7.
42. Schmittagen TD, Zakrajsek BA, Mills AG, Gorn V, Singer MJ, Reed MW. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem. 2000;285:194-204.
43. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nature Protocols. 2007;2:329-33.